Operating Income (Loss) in USD of Medicus Pharma Ltd. from 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Medicus Pharma Ltd. quarterly/annual Operating Income (Loss) history and change rate from 2023 to Q3 2025.
  • Medicus Pharma Ltd. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$15.000.
  • Medicus Pharma Ltd. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$14,727,826.000.
  • Medicus Pharma Ltd. annual Operating Income (Loss) for 2024 was -$11,180,902.000, a 136% decline from 2023.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Medicus Pharma Ltd. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$14,727,826 -$15* +$2,334,246 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 -$17,062,072 -$6,016,088 -$2,462,254 -69.3% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 -$14,599,818 -$5,126,274 -$3,418,916 -2% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025
Q4 2024 -$11,180,902 -$3,585,449 01 Oct 2024 31 Dec 2024 10-K 28 Mar 2025
Q3 2024 -$2,334,261 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 -$3,553,834 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025
Q1 2024 -$1,707,358 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025

Medicus Pharma Ltd. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$11,180,902 -$6,450,957 -1.4% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025
2023 -$4,729,945 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.